TrialJournal of the European Academy of Dermatology and Venereology : JEADV2025

Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials.

Christos C Zouboulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.